Speech perception, real-ear measurements and self-perceived hearing impairment after remote and face-to-face programming of hearing aids: A randomized single-blind agreement study.


Journal

Journal of telemedicine and telecare
ISSN: 1758-1109
Titre abrégé: J Telemed Telecare
Pays: England
ID NLM: 9506702

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 7 11 2019
medline: 13 8 2021
entrez: 8 11 2019
Statut: ppublish

Résumé

Current literature does not provide strong evidence that remote programming of hearing aids is effective, despite its increasing use by audiologists. We tested speech perception outcomes, real-ear insertion gain, and changes in self-perceived hearing impairment after face-to-face and remote programming of hearing aids in a randomized multicentre, single-blind crossover study. Adult experienced hearing aid users were enrolled during routine follow-up visits to audiology clinics. Hearing aids were programmed both face to face and remotely, then participants randomly received either the face-to-face or remote settings in a blinded manner and were evaluated 5 weeks later. Participants then received the other settings and were evaluated 5 weeks later. Data from 52 out of 60 participants were analysed. We found excellent concordance in performance of hearing aids programmed face to face and remotely for speech understanding in quiet (phonetically balanced kindergarten test - intraclass correlation coefficient of 0.92 (95% confidence interval: 0.87-0.95)), and good concordance in performance for speech understanding in noise (phonetically balanced kindergarten +5 dB signal-to-noise ratio - intraclass correlation coefficient of 0.71 (95% confidence interval: 0.55-0.82)). Face-to-face and remote programming took 10 minutes (±2.9) and 10 minutes (±2.8), respectively. Real-ear insertion gains were highly correlated for input sound at 50, 65 and 80 dB sound pressure levels. The programming type did not affect the abbreviated profile of hearing aid questionnaire scores. In experienced hearing aid users, face-to-face and remote programming of hearing aids give similar results in terms of speech perception, with no increase in the time spent on patients' care and no difference in self-reported hearing benefit. NCT02589561.

Identifiants

pubmed: 31694484
doi: 10.1177/1357633X19883543
doi:

Banques de données

ClinicalTrials.gov
['NCT02589561']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-423

Auteurs

Frederic Venail (F)

ENT and Audiology Department, University Hospital Gui de Chauliac, France.
Auditory Disorders, Institute for Neurosciences of Montpellier, INSERM, France.

Marie C Picot (MC)

Biostatistics & Clinical Research Unit, University Montpellier, France.

Gregory Marin (G)

Biostatistics & Clinical Research Unit, University Montpellier, France.

Sylvain Falinower (S)

AudioProConnect Company, France.

Jacques Samson (J)

AudioProConnect Company, France.

Gilles Cizeron (G)

AudioProConnect Company, France.

Maxime Balcon (M)

ENT and Audiology Department, University Hospital Gui de Chauliac, France.
Alliance Audition, Montpellier, France.

Denis Blanc (D)

Audition Conseil, Nîmes, France.

Jeremy Bricaud (J)

Audition Conseil, Perpignan, France.

Antoine Lorenzi (A)

ENT and Audiology Department, University Hospital Gui de Chauliac, France.
Auditory Disorders, Institute for Neurosciences of Montpellier, INSERM, France.
Alliance Audition, Montpellier, France.

Jean-Charles Ceccato (JC)

Auditory Disorders, Institute for Neurosciences of Montpellier, INSERM, France.
Audiology Department and Hearing Aid Dispenser Formation Center, CREFA, University of Montpellier, France.

Jean-Luc Puel (JL)

Auditory Disorders, Institute for Neurosciences of Montpellier, INSERM, France.
Audiology Department and Hearing Aid Dispenser Formation Center, CREFA, University of Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH